Company Overview and News

4
Midstream In Relief

2018-10-07 seekingalpha
Midstream and MLPs had their best day in a few months on Monday (AMZ +2.2%). They struggled to hold those gains the rest of the week, but did finish +1.8% vs. last week, in line with the utilities. Utilities followed a different path to +1.8%, selling off early in the week and rallying to close out the week. With interest rates shooting higher, price action for both midstream and utilities action went against traditional expectations, while the S&P 500 (-1%) and REITs (-3% this week) experienced a more conventional selloff.
TRP DCP NBL WLKP IPL GBNXF KMI TRP KMR PBA CVB IPPLF KMRFZ BPMP

1
WB XPress Project’s Western Build Placed Into Service

2018-10-05 globenewswire
HOUSTON, Oct. 05, 2018 (GLOBE NEWSWIRE) -- TransCanada Corporation (TSX: TRP) (NYSE: TRP) (TransCanada) today announced it has placed the Western Build of its WB XPress (WBX) project into service.
TRP TRP

9
My Big Dividend Payers Are Getting Hit Hard, It's Your Lucky Day

2018-10-05 seekingalpha
While the banks are holding up reasonably well, my pipelines and one of my new utility companies, Bell, are more than out of market favour.
TRP RCI TNTTF BMO ENB TD BMO BCE ENB RY BNS CM TRP TD TU

6
Can Mega LNG Export Project Take Canada to New Heights?

2018-10-04 zacks
Previously a booming market, the Canadian energy sector has not witnessed any major milestones since the past few years. Industry downturn coupled with U.S. shale revolution hit the country hard, nullifying years of expansionary phase within Canada’s energy industry. With the cancellation of major projects like Northern Gateway, Pacific NorthWest and Energy East along with uncertainties relating to the existing ones, things have been quite dispiriting for investors in the Canadian oil energy space.
TRP RDS.B RDS.A RDSB RDSA KMI CSBR TRP RYDBF FLR RYDAF KMR CVB KMRFZ

2
Pembina Pipeline: Why This Pipeline Operator Is Poised To Outperform Its Peers

2018-10-02 seekingalpha
Its long-term performance is outstanding, and the company has outperformed the broader market by triple-digit figures.
ENB TRP PPL TRP ENB PBA

1
Green Light For The Massive LNG Canada Project

2018-10-02 seekingalpha
I provide a list of companies mainly producing natural gas in Canada. But some of them need better gas prices before the LNG export facility becomes operational.
TRP TRP

4
Thinking About Investing In Canadian Midstream, Eh?

2018-09-26 seekingalpha - 1
Over time, the US and Canadian energy markets have become more integrated. Energy trade and cross-border asset ownership are just some examples of this interconnectedness. Enbridge's (NYSE:ENB) simplification plan, which includes acquiring its sponsored MLPs Spectra Energy Partners (NYSE:SEP) and Enbridge Energy Partners (NYSE:EEP), is a company-level example of the overlap between US and Canadian midstream.
TRP DTK ENB ALJ KEY IPL SEP ENB ALDW KEY TRP EEP PBA IPPLF

5
Oil & Gas Stock Roundup: TOTAL's Acquisition, Cheniere's LNG Supply Deal & More

2018-09-25 zacks
It was a week where oil prices surged above $70, while natural gas futures crept ever closer to the psychologically important $3 level.
BHI TRP CQP CLNE LNG TRP WRD RIG LNG CEO SGAZF

2
TransCanada's Keystone XL Gets Nod From U.S. State Department

2018-09-25 zacks
Bringing in pleasant news for TransCanada Corporation (TRP - Free Report) , the U.S. State Department has finally green-lighted the company’s controversial Keystone XL project. Just a month back, a U.S. federal judge, Brian Morris, issued a decree requiring the State Department to conduct a fresh environmental evaluation of the Keystone XL pipeline under the new alternative route. The judge believed that the alternative route proposed by the Nebraska Public Utilities Commission had not been properly assessed.
TRP ATP AT TRP RGCO APRWF

1
Waterlogged Midstream

2018-09-24 seekingalpha
Another up and down week in midstream, but this time midstream corporations were up and MLPs were down, although the move was small in both directions. Midstream outperformed utilities, which sold off on higher interest rates. The S&P 500 beat both midstream and utilities.
TRP TRP

2
Boston Pizza: Headwinds Continue

2018-09-18 seekingalpha
Boston Pizza Royalties Income Fund collects about 4% of royalty income from its 391 restaurants across Canada.
ENB TRP TRP ENB BPZZF

10
AltaGas: Abandoning Canada, Will The Company Win Over U.S. Investors?

2018-09-17 seekingalpha
AltaGas has been consistently investing in U.S. projects over Canadian ones. Recent divestitures to fund the U.S. based WGL Holdings acquisition have tilted Canadian.
SOJA DUKH SO TRP SCG WGL DTK DUK ENB ENB ATGFF EQT WMB TRP ED PBA

25
Pipeline Challenges in U.S. & Canada Continue Amid Oil Boom

2018-09-14 zacks
Oil production is surging in North America but producers are far from happy as their profit margin is sinking. They are struggling to stay competitive owing to the infrastructural bottlenecks. As if the pipeline pinch problem was not enough for the United States and Canada, raging protests against the already approved and existing pipeline projects have made things worse.
DCUB SOJA DCUA DCUD DCUC CY UGI WGL ENB SJIU EQM KMI DRUA TRP EBBNF PAA ED KMR CVB NEE SO ENBBF DUKH TRP SJI D NJR DUK RGCO ENB ETP KMRFZ GJP

1
Une présentation par TransCanada lors de l’Energy Conference de Peters & Co.

2018-09-11 globenewswire
CALGARY, Alberta, 11 sept. 2018 (GLOBE NEWSWIRE) -- Communiqué de presse – Karl Johannson, président et vice-président directeur, énergie et pipelines de gaz naturel au Canada et au Mexique, TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada), fera une présentation à la 22e Energy Conference annuelle de Peters & Co. Limited à Toronto, le 12 septembre 2018.
TRP TRP

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:TRP / Transcanada Corp. on message board site Silicon Investor.

ITRP - Intrepid Technology u0026 Resources, Inc. ITRP - Intrepid Technology u0026 Resources, Inc. ITRP - Intrepid Technology u0026 Resources, Inc. TRPH TriPath Technology Inc. TRPH TriPath Technology Inc. TRPH TriPath Technology Inc.
transcanada pipelines (TRP) transcanada pipelines (TRP) transcanada pipelines (TRP) Tripath Technology, Inc. (Nasdaq:TRPH) Tripath Technology, Inc. (Nasdaq:TRPH) Tripath Technology, Inc. (Nasdaq:TRPH)
Tripos (TRPS): Will Surge! Tripos (TRPS): Will Surge! Tripos (TRPS): Will Surge!